Express Scripts' Three-Year Drug Trend Forecast Projects That Three of the Four Costliest Therapy Classes Will Be Specialty Conditions ST. LOUIS, May...
Study Shows Effects of Treatment with ABILIFY MAINTENA™ (Aripiprazole) on Psychiatric Hospitalization Rates for Patients with Schizophrenia...
Vortioxetine, a new multimodal agent in development for the treatment of major depression, shows effects on cognitive function in several preclinical...
Over the past two years, two studies showed the Niaspan cholesterol drug did not benefit patients. Yet AbbVie has managed to maintain revenue...
A shiny day here in the nation's medicine cabinet. We are spending a great deal of time chatting with interesting people and reading up on various things. Meanwhile, we thought to share with you some of the interesting tidbits that have floated by...
AstraZeneca CEO Can't Predict Jupiter Impact (Dow Jones)
Bayer Clot Drug Misses Midstage Study Goal (Yahoo/Reuters)
Pfizer's Indiana Plant Is For Sale (The Indianapolis Star)
Exelixis Lays Off 10 Percent Of Staff (San Francisco Business Times)
